Avrio Capital invests in bio-based materials specialist POS
Canadian venture capital firm Avrio Capital has invested in POS Bio-Sciences Inc, a Saskatoon-based contract research organization offering process development, analytical and custom processing services for the bioprocessing industries. No financial terms were released for the investment, the sixth made to date by Avrio Ventures III, which raised $110 million last year. Avrio Managing Director Steven Leakos said the deal will help POS make the transition from a primary research focus to “a product-focused platform.” Founded in 1973, the company is led by CEO Dale Kelly. In March, Avrio invested in the US$6.5 million Series A financing of Farmlead Inc.
20 June 2017•3 mins read
